The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.
about
Managing Neuropathic Pain in DogsGlutamatergic transmission in drug reward: implications for drug addictionIt's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer modelThe cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.In vivo opioid receptor heteromerization: where do we stand?Neuroanatomical evidence of the melanocortin-4 receptor expression in the mesencephalic periaqueductal gray innervating renal tissuesMemantine improves buprenorphine/naloxone treatment for opioid dependent young adultsPhosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal.Hint1 gene deficiency enhances the supraspinal nociceptive sensitivity in mice.Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models.Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.Opioid administration following spinal cord injury: implications for pain and locomotor recovery.Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling.The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin.Opioids Resistance in Chronic Pain Management.Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineThe absolute bioavailability of racemic ketamine from a novel sublingual formulation.Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats.Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.The stem bark extracts of Cenostigma macrophyllum attenuates tactile allodynia in streptozotocin-induced diabetic rats.LncRNA expression in the spinal cord modulated by minocycline in a mouse model of spared nerve injury.Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys.Enhancement in Tonically Active Glutamatergic Inputs to the Rostral Ventrolateral Medulla Contributes to Neuropathic Pain-Induced High Blood Pressure.Schizophrenia and depression, two poles of endocannabinoid system deregulation.Switch-on fluorescent/FRET probes to study human histidine triad nucleotide binding protein 1 (hHint1), a novel target for opioid tolerance and neuropathic pain.Inhibition of β-ARK1 Ameliorates Morphine-induced Tolerance and Hyperalgesia Via Modulating the Activity of Spinal NMDA Receptors.Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain.Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.Sigma 1 Receptor Antagonists Inhibit Manic-like Behaviors in Two Congenital Strains of Mice.Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology
P2860
Q26768216-8B3A07FB-D327-49AE-AA7A-2B3046A530D5Q28112161-6E342E83-4503-41E5-8F53-B5075699E2DFQ30437184-4334E489-B666-4896-BD46-24669742562FQ34439601-11E29149-E4F1-4CCF-BF34-A2D1F7C7BE1AQ34659000-BEB3D1DD-6106-411C-AB99-6D99D8CB4579Q34939677-2496B48A-FE95-4FCA-ABF4-067DC1CA0C53Q35679471-3F8CF1A5-66FA-451C-832A-EE8795390E70Q36297525-121E2F7A-6E74-4CB6-9DEA-63BEE4DB084AQ36316449-01778F20-A42C-4D60-8A3C-9CF282888CF1Q36948351-E75FE6A2-0D3E-4D0D-8329-1E891C753DD8Q37114799-3A1E9E92-5669-4E20-BB71-63D06EABB031Q37137778-82B1C99F-BE29-4578-9B11-07E3D7AD010CQ37306525-D176D412-102E-499B-A9BA-F6F53F598D7FQ37364657-6ED93BA1-2DCC-4DA6-94CB-2DBE726E91D0Q38090368-8790D5A1-4023-4150-9B9E-0D5BE6714E1BQ38105951-64AE8CA0-1740-4A9F-B0E2-77AE49DC8F7FQ38262682-DA71A60F-5C9D-4C0A-BD9B-895EEB8A01B4Q38527782-976AB80C-77AD-4AFC-BA6F-214629D6E831Q39305721-D4A40D42-DF0C-42C9-9082-CB0E3A8E75DAQ40197087-0F3A009C-A92B-43CD-A2EA-27D8D259A3ACQ41572995-151E9191-4C6F-499C-9A8B-703AC5C64639Q42283150-281F7D7F-EEF3-448F-8424-515430F20A7DQ42317501-9F4187C9-DF6B-4880-B03D-78BE94274218Q42872711-A42E216C-EF54-4C6E-8AD6-DA64B5255F1AQ43195386-0BE3C3F1-D7FE-4D11-AD9A-FBB434211B14Q44128577-ACD83855-16D2-437D-BAD4-0EB0CD9D3F9AQ44336573-0086C892-C617-4AF6-ACBA-904821AFCD67Q44349884-BAED8A86-BAA7-49CB-8E9D-ACD620485B60Q44364773-B321AD80-F83F-49BF-AAE0-0975E26BE10DQ44823851-38F10255-FEC6-4687-B9F5-87739CA3BA26Q46264993-A1467259-C874-443F-9D3C-4BD54987DECBQ47131988-2B0527E8-9637-4401-A272-38B04AE8EAA1Q47284001-B6F6AF56-1818-4B88-B648-09C54C09ACD1Q47362986-A6585BD9-C475-43BF-955B-CE039EE5C483Q47702437-9D0210F5-4C9E-4118-A4DB-D91DF0F9DA26Q48218946-66D40AF6-B9E6-44A8-8647-A273CE111DF9Q48405754-DC707854-9066-4F94-AF7A-57353C797943Q51750311-07ADAADC-971C-47AA-9DD3-FD72E0E8B45DQ54977290-C5230EB1-7138-46FE-A544-4C5A5D31131FQ57462903-C1EFA286-4557-4B59-915C-D8B82E1CC026
P2860
The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The mu-opioid receptor and the ...... implications in pain control.
@en
The mu-opioid receptor and the ...... implications in pain control.
@nl
type
label
The mu-opioid receptor and the ...... implications in pain control.
@en
The mu-opioid receptor and the ...... implications in pain control.
@nl
prefLabel
The mu-opioid receptor and the ...... implications in pain control.
@en
The mu-opioid receptor and the ...... implications in pain control.
@nl
P2860
P50
P356
P1476
The mu-opioid receptor and the ...... : implications in pain control
@en
P2093
Ana Vicente-Sánchez
María Rodríguez-Muñoz
P2860
P2888
P304
P356
10.1038/NPP.2011.155
P407
P577
2011-08-03T00:00:00Z